Statement Of Comprehensive Income [Abstract]

Biotest AG - Filing #6464577

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Statement of comprehensive income [abstract]
Profit (loss)	– EUR	264,000,000 EUR	– EUR	– EUR	– EUR	264,000,000 EUR	– EUR	1,270,000,000 EUR	– EUR	1,270,000,000 EUR	– EUR	– EUR
Other comprehensive income [abstract]
Other comprehensive income that will not be reclassified to profit or loss, net of tax	—	30,000,000 EUR	—	—	—	—	—	20,000,000 EUR	—	—	—	—
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Gains (losses) on exchange differences on translation of foreign operations, net of tax	—	42,000,000 EUR	—	—	—	—	—	28,000,000 EUR	—	—	—	—
Reclassification adjustments on exchange differences on translation of foreign operations, net of tax	—	– EUR	—	—	—	—	—	3,000,000 EUR	—	—	—	—
Other comprehensive income that will be reclassified to profit or loss, net of tax	—	42,000,000 EUR	—	—	—	—	—	28,000,000 EUR	—	—	—	—
Other comprehensive income	– EUR	72,000,000 EUR	– EUR	42,000,000 EUR	30,000,000 EUR	– EUR	– EUR	8,000,000 EUR	20,000,000 EUR	– EUR	– EUR	28,000,000 EUR
Comprehensive income	– EUR	336,000,000 EUR	– EUR	42,000,000 EUR	30,000,000 EUR	264,000,000 EUR	– EUR	1,278,000,000 EUR	20,000,000 EUR	1,267,000,000 EUR	– EUR	31,000,000 EUR
Comprehensive income attributable to [abstract]
Comprehensive income, attributable to owners of parent	—	336,000,000 EUR	—	—	—	—	—	1,278,000,000 EUR	—	—	—	—